Nintedanib reduces severity of post-traumatic joint contracture by modulating fibrosis and inflammation
{{output}}
This study investigates the potential of nintedanib, a tyrosine kinase inhibitor with antifibrotic and anti-inflammatory properties, to mitigate post-traumatic joint contracture (PTJC) in a rat model. Given the lack of effective pharmacological treatments for ... ...
